cookie

We use cookies to improve your browsing experience. By clicking «Accept all», you agree to the use of cookies.

avatar

Covid Vaccine Victim Awareness Month

Information Channel for Covid Vaccine Victim Awareness Month January 2023. You will find information Leaflets, Rally Dates and Outreach Campaign information here.

Show more
The country is not specifiedEnglish97 645Medicine9 174
Advertising posts
1 430Subscribers
-324 hours
-147 days
-4230 days

Data loading in progress...

Subscriber growth rate

Data loading in progress...

MHRA YELLOW CARD REPORTING SUMMARY UP TO 25th OCT 2023 New interactive format data   Adult & Child - Primary, Third Dose & Boosters (mono/bivalent)   Government data (archived) up to Sept 2022 showed 53.8 million people had received a 1st dose UK-wide By week ending 3 November 2023, 63.2% (7,050,519 out of 11,164,326) of all people aged over 65 years old who are living in England have been vaccinated with an autumn 2023 booster dose. National Influenza and COVID-19 surveillance report - Week 45 Yellow Card Adverse Event Reports 177,860 (Pfizer-mono) 5777 (Pfizer-bivalent) 248,834 (AZ) 43,075 (Moderna-mono) 5580 (Moderna-bivalent) 111 (Novavax) 2761 (Unknown brand) TOTAL = 483,998 people impacted (increase of 1355 in 4 weeks)   Reports classified as SERIOUS* by MHRA = 74.5% of all reports 125,965 (Pfizer-mono) + 4449 (Pfizer-bivalent) + 192,823 (AZ) + 31,178 (Moderna-mono) + 4087 (Moderna-bivalent) + 81 (Novavax) + 1985 (Unknown) = 360,568 Over 46,569 of the above serious reports are of ‘Unknown Age’ = 12.9% of all serious reports    Reports classified as Non-SERIOUS by MHRA = 25.0% 51,001 (Pfizer-mono) + 1275 (Pfizer-bivalent) + 54,594 (AZ) + 11,802 (Moderna-mono) + 1444 (Moderna-bivalent) + 30 (Novavax) + 688 (Unknown) = 120,834     Overall 1-in-111 people injected experiences a Yellow Card Adverse Event (assuming one person submits only one report) 1-in-149 people injected experiences an adverse event classified as SERIOUS* 1-in-186 reports are associated with a fatality, which may be less than 10% of actual figures according to MHRA Reactions 513,725 (Pfizer-mono) 15,625 (Pfizer-bivalent) 882,871 (AZ) 141,618 (Moderna-mono) 15,353 (Moderna-bivalent) 322 (Novavax) 8437 (Unknown) TOTAL = 1,577,951   Fatal 894 (Pfizer-mono) 53 (Pfizer-bivalent) 1417 (AZ) 95 (Moderna-mono) 49 (Moderna-bivalent) 88 (Unknown) TOTAL = 2596 = 0.5% of all reports (increase of 16 reports with fatal outcome in 4 weeks)   406 of the above fatalities are of ‘Unknown Age’ = 15.6% of all fatalities, and >146 are of ‘Unknown Sex’ = 5.7% of all fatalities * MHRA definition of ‘serious’ - patient died, life threatening, hospitalisation, congenital abnormality, persistent or significant disability or capacity, deemed medically significant by MHRA medical dictionary or reporter   For full reports - https://yellowcard.mhra.gov.uk/idaps
Show all...

👍 2 1😢 1
WORLD WIDE RALLY FOR FREEDOM & I WILL NOT COMPLY! LONDON, ENGLAND 1 PM SAT 23RD SEPTEMBER HYDE PARK SPEAKERS CORNER #IWillNotComply #WeDoNotConsent
Show all...
9🔥 1
MHRA YELLOW CARD REPORTING SUMMARY UP TO 30th AUG 2023 New interactive format data   Adult & Child - Primary, Third Dose & Boosters (mono/bivalent) Government data (archived) up to Sept 2022 showed 53.8 million people had received a 1st dose UK-wide By week ending 2 July 2023, 71.1% (3,856,204 out of 5,423,074) people aged over 75 years old and 41.2% (915,421 out of 2,223,120) people aged 5 years and over who are immunosuppressed (England only) had a Spring 2023 booster since 3 Apr 2023 UKHSA National Flu & Covid-19 Surveillance Report - week 35 Yellow Card Adverse Event Reports - 177,307 (Pfizer-mono) + 5034 (Pfizer-bivalent) + 248,490 (AZ) + 43,009 (Moderna-mono) + 5463 (Moderna-bivalent) + 82 (Novavax) + 2602 (Unknown brand) = 481,987 people impacted (increase of 329 in 5 weeks)   Reports classified as SERIOUS* by MHRA = 74.5% of all reports 125,558 (Pfizer-mono) + 3897 (Pfizer-bivalent) + 192,550 (AZ) + 31,124 (Moderna-mono) + 3991 (Moderna-bivalent) + 60 (Novavax) + 1887 (Unknown) = 359,067 Over 46,328 of the above serious reports are of ‘Unknown Age’ = 12.9% of all serious reports    Reports classified as Non-SERIOUS by MHRA = 25.0% 50,856 (Pfizer-mono) + 1093 (Pfizer-bivalent) + 54,527 (AZ) + 11,793 (Moderna-mono) + 1424 (Moderna-bivalent) + 22 (Novavax) + 629 (Unknown) = 120,344     Overall 1-in-112 people injected experiences a Yellow Card Adverse Event (assuming one person submits only one report) 1-in-150 reports are classified as SERIOUS* 1-in-187 reports are associated with a fatality, which may be less than 10% of actual figures according to MHRA Reactions - 512,038 (Pfizer-mono) + 13,515 (Pfizer-bivalent) + 881,718 (AZ) + 141,326 (Moderna-mono) + 14,986 (Moderna-bivalent) + 250 (Novavax) + 8005 (Unknown) = 1,571,838   Fatal - 893 (Pfizer-mono) + 44 (Pfizer-bivalent) + 1413 (AZ) + 92 (Moderna-mono) + 48 (Moderna-bivalent) + 86 (Unknown) = 2576 = 0.5% of all reports (increase of 12 reports with fatal outcome in 5 weeks)   Over 405 of the above fatalities are of ‘Unknown Age’ = 15.7% of all fatalities, and >147 are of ‘Unknown Sex’ = 5.7% of all fatalities    CHILDREN & YOUNG PEOPLE SPECIAL REPORT 4,213,500 children (1st doses) - majority Pfizer (latest available dose total from Nov 2022)   Yellow Card Adverse Events Reported - Below combined 0-19yrs - many categories “retracted (^) due to less than 5 reports in line with MHRA duty of confidentiality to patients and reporters”   0-19yr old reports classified as SERIOUS* by MHRA = 71.4% 4679 (Pfizer-mono) + >41 (Pfizer-bivalent) + 1462 (AZ) + 518 (Moderna-mono) + >7 (Moderna-bivalent) + >36 (Unknown) = 6743    0-19yr old reports classified as FATAL by MHRA >11 (Pfizer-mono) + <5 (Pfizer-bivalent) + <5 (AZ) + <5 (Moderna-mono) + <5 (Moderna-bivalent) + <5 (Unknown brand) = greater than 17 20-29yr old reports classified as SERIOUS* by MHRA = 73.3% 20,039 (Pfizer-mono) + 127 (Pfizer-bivalent) + 14,569 (AZ) + 4985 (Moderna-mono) + 137 (Moderna-bivalent) + < 5 (Novavax) + 99 (Unknown) = 39,956    20-29yr old reports classified as FATAL by MHRA 15 (Pfizer-mono) + <5 (Pfizer-bivalent) + 29 (AZ) + zero (Moderna-mono) + zero (Moderna-bivalent) + zero (Novavax) + <5 (Unknown brand) = greater than 45   * MHRA definition of ‘serious’ - patient died, life threatening, hospitalisation, congenital abnormality, persistent or significant disability or capacity, deemed medically significant by MHRA medical dictionary or reporter   For full reports - https://yellowcard.mhra.gov.uk/idaps
Show all...

Repost from Fiona Rose Diamond
“He was given 7 years to live with his illness, he lasted just 1 year in the new NHS system. “I’ve also witnessed the desperation of families witnessing their own relatives dying sooner than they should have due to the lack of professional care that should have been provided. It has been a very sad year in which I have witnessed the demise of the health service. “I have also seen stroke patients sent home without being given any follow-up care. I also know of a triage policy in which staff were forced to send potentially seriously ill people home on the premise of giving them a call if their condition worsened”. https://www.nice.org.uk/guidance/ng163 When you read NG163, note the date – 3rd April 2020. This was less than 2 weeks after the UK entered lockdown. Even if we concede that NICE, via the government, were working on treatment guidelines from January 2020, when early reports of Covid 19 were circulating around the world, that would have given NICE only 3 months to formulate the guidance in NG163. It is inconceivable that NICE could have the evidence and effective information about the use of Midazolam and Opioids for the treatment of breathlessness and anxiety in Covid 19, within this time frame. Read the full Article here: https://expose-news.com/2023/08/30/we-were-told-kill-patients-pandemic/
Show all...
👍 1😢 1
Repost from WTF is Going On
I had the pleasure of meeting Ali Lilley at a freedom fest in Leicester early August 2023, Ali agreed to allow me to film her and share her story. ❤️ The struggle to get acknowledgement for vaccine injury is very real. Both Ali and Her brother Pete (who died shortly after the Astrazeneca Vaccine - apparently just a 'mild reaction') have not got the acknowledgement and Justice they deserve. Ali continues to fight for Justice with the help of CVIB www.cviblegalfund.co.uk founded by Alex Kelly, who lost her mother Anthea 4 days after 1 dose of the Astrazeneca vaccine. Syston & District Social club, Freedom fest Aug 11th 2023 ,Leicester https://linktr.ee/WTFisGoingOnOfficial
Show all...
7🔥 1
Repost from Fiona Rose Diamond
BRILLIANT! This is the message we need to be sending on SATURDAY 23RD SEPTEMBER at World Wide Rally For Freedom across the world! Join us in London, UK (location will be released very soon!) And if you can't make London, try to get to Manchester, Cardiff or Aberdeen! Perhaps we should all learn the lyrics and make some noise on the day (remember, they now don't like 'disruptive' or noisy protests!)!? 'I will not comply Quit tryna take me to task 'cause I don't wanna wear a mask Could take a vaccine that could maybe make me die They got no scientific evidence to back that crap up All they do is feed us lie after lie That's why I will not comply' #IWillNotComply More information about all UK locations for World Wide Rally For Freedom can be found here: https://t.me/NationwideRalliesForFreedom 'Blind Joe: I Will Not Comply' https://youtube.com/@blindjoemusic @FionaRoseDiamond
Show all...
❤‍🔥 5👍 1
Repost from Fiona Rose Diamond
'COVID-19 DEATHS' BY VACCINATION STATUS FROM JAN-MAY 2023. More proof from Office For National Statistics that 'it' is NOT safe and it is definitely NOT effective! https://t.me/worlddoctorsalliance/29930 Not only are we seeing excess deaths (see link above) but for the first time PROOF from ONS of something that yes, WE knew already.... As people keep saying, whatever happens next, do not comply! @FionaRoseDiamond
Show all...
While we have electron microscopy, DARPA projects in virus gain of function bionanotechnology biolabs use atomic force microscopy. This is how they are many steps ahead than non military labs. @RobinMG https://t.me/robinmg/29831 https://twitter.com/robinmonotti/status/1695815786672095472
Show all...
Robin Monotti + Dr Mike Yeadon + Cory Morningstar

ATOMIC FORCE MICROSCOPY in VIROLOGY: "Viruses are small agents that infect all types of organisms, from animals to plants to bacteria. Viruses are also among the most serious pathogens in human history. Understanding the molecular basis of viruses has the potential to yield new and exciting strategies for therapeutic treatments. However, the methods currently available to treat virus infections are not always helpful. Part of the reason for this is that the development of affective strategies for virus treatments is limited by a lack of knowledge of viruses. In order to have a real understanding of viruses, direct visualization of virus particles is sometimes required. The sizes of viruses range from 20 to 250–400 nm, which is beyond the resolution range of conventional optical microscopy, so visualization of virus particles was carried out by electron microscopy. Its high resolution and relatively simple sample preparation mean that the atomic force microscope has become a new option for direct virus imaging.…

ATOMIC FORCE MICROSCOPY in VIROLOGY: "Viruses are small agents that infect all types of organisms, from animals to plants to bacteria. Viruses are also among the most serious pathogens in human history. Understanding the molecular basis of viruses has the potential to yield new and exciting strategies for therapeutic treatments. However, the methods currently available to treat virus infections are not always helpful. Part of the reason for this is that the development of affective strategies for virus treatments is limited by a lack of knowledge of viruses. In order to have a real understanding of viruses, direct visualization of virus particles is sometimes required. The sizes of viruses range from 20 to 250–400 nm, which is beyond the resolution range of conventional optical microscopy, so visualization of virus particles was carried out by electron microscopy. Its high resolution and relatively simple sample preparation mean that the atomic force microscope has become a new option for direct virus imaging. The atomic force microscope has been applied to image virus morphology on tobacco mosaic virus and other large plant viruses in their crystalline form, and the Moloney murine leukemia virus and HIV on cell surfaces. Images of single virus particles of the herpes virus, vaccinia virus, and minivirus have also been achieved using AFM. AFM has also been applied to measure the triangulation number, T, in the icosahedral capsid of Ty3 protoretrovirus. These studies have given great insight into how viruses are assembled and formed, and how virus components are organized in intact virus particles. Although the morphologies of virus particles have been imaged using AFM, the pathogenicity of viruses is related to many other parameters that should be addressed. For this, the AFM has been applied to investigate the auto-assembly process of the core proteins of the HIV and Mason-Pfizer monkey viruses. In this study, the importance of the deletion of a proline residue at the N-terminus in a mature virus capsid protein on the formation of sphere-shaped virus capsids was observed. The authors also suggested the roles played by capsid protein–RNA associations on maintenance of the regular assembly of HIV core-like particles based on AFM observations. The self-assembled particles of the recombinant hepatitis B virus (HBV) core antigen and its mutants expressed in the yeast Saccharomyces cerevisiae system were also analyzed by AFM [23], [24]. The authors found that there were two populations of HBV core particles of different sizes formed in the yeast expression system they applied, and these were also found in the native particles isolated from human liver. The size distributions of the particles isolated from the yeast expression system and human liver were nearly identical. They also found that the sequence of the HBV core protein between amino acids 81 and 116, which is a recognition site for human T-cells, was not important for virus core assembly. This finding could imply that the mutations within this region could help the virus escape attack from the human immune system without affecting virus assembly. Fig. 2. (A) Atomic force microscope (AFM) three-dimensional image of three core-like particles assembled by hepatitis C virus core protein 1-116. The particles were assembled by dialysis against phosphate buffered saline (PBS), pH7.0, and imaged in PBS pH7.0 on a mica surface. (B) AFM image of a flagellated E. coli cell. The E. coli cell is in its late log phase, and was twice washed with PBS to remove the culture medium and air-dried on mica surfaces for imaging. (C) Three-dimensional view of the cytoskeleton network of an A549 cancer cell imaged by the AFM. In addition to the complex cytoskeleton network, tiny protrusions around the cell edge are also visible. This cell was fixed with a standard glutaraldehyde method on a glass cover-slide." https://t.me/robinmg/29830 https://www.sciencedirect.com/science/article/pii/S1016319012000845
Show all...
Robin Monotti + Dr Mike Yeadon + Cory Morningstar